Related content

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

By Namouni F.   Doz F.   Tanguy M.L.   Quintana E.   Michon J.   Pacquement H.   Bouffet   Gentet J.C.   Plantaz D.   Lutz P.   Vannier J.P.   Validire P.   Neuenschwander   Desjardins L.   Zucker J.M.  

European Journal of Cancer, Vol. 33, Iss. 14, 1997-12 ,pp. : 2368-2375

Elsevier

Access to resources Recommend Favorite

Considerable Plasma Levels of a Cytotoxic Etoposide Metabolite in Patients Undergoing High-dose Chemotherapy

By Stremetzne S.   Jaehde U.   Kasper R.   Beyer J.   Siegert W.   Schunack W.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 978-979

Elsevier

Access to resources Recommend Favorite

High-dose Carboplatin and Etoposide for Salvage Chemotherapy of Germ Cell Tumours

By Dearnaley D.P.   Lampe H.   Price A.   Mehta J.   Powles R.   Nicholls J.   Horwich A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 717-723

Elsevier

Access to resources Recommend Favorite

Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By de Jong R.S.   Hofstra L.S.   Willemse P.H.B.   de Bruijn H.W.A.   de Vries E.G.E.   Boonstra H.   Mulder N.H.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin)-chemotherapy selected for multidrug resistance modulation

By Davidson A.   Dick G.   Pritchard-Jones K.   Pinkerton R.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2422-2427

Elsevier

Access to resources Recommend Favorite